HCM
HELP

Horrell Capital Management’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Horrell Capital Management’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-263
Closed -$5K – 208
2022
Q3 		$5K Buy
+263
New +$7.12K ﹤0.01% 177

Other funds holding HELP

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
IWP
IAG Wealth Partners Waukesha, Wisconsin $1.01B AUM 17.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Horrell Capital Management's HELP Position: Q4 2022 in Review

Horrell Capital Management sold out of Helus Pharma Inc. Common Stock (HELP) in Q4 2022, closing a stake of 263 shares — an estimated $5K sold.

Horrell Capital Management first reported a position in HELP in Q3 2022 and held it in 1 quarter. The position peaked at $5K in Q3 2022. 70 funds tracked by Wall St. Rank hold HELP as of Q4 2022.

  • Horrell Capital Management reported no remaining Helus Pharma Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Horrell Capital Management sold 263 Helus Pharma Inc. Common Stock shares in Q4 2022, an estimated $5K.
  • Horrell Capital Management first reported a position in Helus Pharma Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Horrell Capital Management's Helus Pharma Inc. Common Stock position peaked at $5K in Q3 2022.
  • 70 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q4 2022.

Based on Horrell Capital Management's 13F filing for Q4 2022, filed 30 Jan 2023.